Last reviewed · How we verify
NCT06742255
Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients
trial testing Stellate Ganglion Block in Stellate Ganglion in 34 participants. Not yet recruiting.
20 December 2024
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 34 |
| Start date | 20 December 2024 |
| Primary completion | 20 December 2024 |
| Estimated completion | 20 December 2024 |
Drugs / interventions tested
- Stellate Ganglion Block — full drug profile →
Conditions studied
- Stellate Ganglion — all drugs for Stellate Ganglion →
- Facial Palsy — all drugs for Facial Palsy →
- Pain Management — all drugs for Pain Management →
Sponsor
Assiut University
Who can join
Eligibility, any sex, with Stellate Ganglion or Facial Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of the present study is to verify the efficacy of stellate ganglion block (SGB) in the treatment of facial pain
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06742255
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Stellate Ganglion Block
Trials testing the same drug.
- NCT06570213 — Evaluating The Efficacy Of Combined Cognitive Processing Therapy and Stellate Ganglion Blocks for PTSD · EARLY_PHASE1 · not yet recruiting
- NCT07271615 — Effect of Preoperative Stellate Ganglion Block on Postoperative Atrial Fibrillation After Coronary Artery Bypass Graftin · NA · recruiting
- NCT07129811 — Stellate Ganglion Block in Complex Regional Pain Syndrome · NA · recruiting
- NCT06646081 — The Impact of Greater Occipital Nerve and Stellate Ganglion Block Treatments on Sleep in Chronic Headache Management · NA · not yet recruiting
- NCT06540313 — Efficacy, Safety and Neural Mechanism of Stellate Ganglion Block in the Treatment of Anxiety. Disorder. · NA · not yet recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06742255 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 19 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06742255.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing